LMAT-LeMaitre Vascular Stock Research, Ratings, and Analysis

LeMaitre Vascular (lmat) Stock Research

Last Updated by Anonymous | Update This Page Now

►Summary | Profile | News | Chart | SWOT | Cash Flow | Comps | Buffett | WACC

Company Description: LeMaitre Vascular, Inc., founded in 1983, develops and manufactures medical products for the treatment of vascular disease, including the EndoFit Thoracic Stent Graft used for the repair of thoracic aortic aneurysm and dissection, the UniFit Abdominal Stent Graft for abdominal aortic aneurysm, the AnastoClip Vessel Closure System for the attachment of blood vessels, and the Albograft Vascular Graft for use in bypass and replacement procedures. Headquartered in Burlington, Massachusetts, LeMaitre Vaascular sells its products to surgeons in the United States and internationally. Update

Market Research Update

Health Care Industry Research & Analysis: The health care industry depends on the care of health-related services by professionals for the benefit of patients. Medical device markers, insurance companies, pharmaceutical drug developers and government institutions are major participants in the treatment of sick, injured and disabled patients. Health Care Trading Strategy: Health Care stocks tend to be less sensitive to economic changes. Look for undervalued health care investments at any point in the business cycle when stock prices are low. However, biotech, employment staffing and insurance companies may all decrease during recessions for different reasons. Government intervention is another important factor in health care investments, since government spending in health care is a very large portion of overall health care spending. When governments change spending plans, different sub-sectors in the industry are significantly affected. Upward sloping stock charts and financial news may indicate a selling opportunity while the opposite means that stocks are becoming undervalued.

Industry Sub Sector: . The market is quickly expanding. This lowers the threat of direct competition and increases LeMaitre Vascular's profits.

Market Challenges: Opportunities: Solutions:

Strategy Analysis Update

LeMaitre Vascular's business strategy is to keep things simple. Clearly-defined strategies lower business risks by staying within their areas of expertise.

Strategy: LeMaitre Vascular has a narrow focus that serves a particular customer niche with either a unique product or with a low cost advantage over competitors. (read more). Competitive Advantages:

Financial Analysis Update

Current Revenue Sources: Future Revenue Sources: